Langensendelbach, Bavaria, Germany
I am a professional translational neuroscientist with a track record in the academic and start-up ecosystems. • Business acumen as serial Chief Medical Officer and Chief Scientific Officer • Hands-on experience in medical devices, biotechnology, and digital therapeutics • International experience in Denmark, France, Italy, The Netherlands, and the US • Over 90 peer-reviewed publications in scientific journals • Award-winning presentations at scientific conferences • Adjunct professor of medical neurosciences at the University of Erlangen-Nuremberg • Key indication areas: Neurology, Neurosurgery, Psychiatry, Ophthalmology, and Pain Medicine I perform the following key tasks: • Navigating through the gates of translational neuroscience • Benchmarking medical business cases against published evidence • Ensuring that the medical story is bulletproof • Identifying medical gaps and development of strategies to eliminate them • Creating research and development plans • Execution of preclinical and human experimental studies, as well as clinical trials • Support of regulatory pathways in the EU (CE) and the US (FDA)
Disruptive neurotechnologies and digitization revolutionize medical diagnostics and treatment of brain disorders. With a strong background and a track record in clinical neurosciences, I joined medical device industry in 2010. I appreciate the opportunity to facilitate clinical development, regulatory affairs, and medical affairs and to be part of a team that aims at innovations for patients with unmet medical needs.
Electrical Optic Nerve Stimulation triggers neurorestoration and neuroprotection in glaucoma patients with progressive vision loss.
Dopavision is pioneering the development of digital therapeutics in ophthalmology.